A detailed history of Grayhawk Investment Strategies Inc. transactions in Viatris Inc stock. As of the latest transaction made, Grayhawk Investment Strategies Inc. holds 148 shares of VTRS stock, worth $1,924. This represents 0.0% of its overall portfolio holdings.

Number of Shares
148
Previous 148 -0.0%
Holding current value
$1,924
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$9.2 - $12.26 $239 - $318
26 Added 21.31%
148 $1,000
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $226 - $300
-26 Reduced 17.57%
122 $1,000
Q2 2022

Aug 11, 2022

BUY
$9.95 - $12.27 $1,472 - $1,815
148 New
148 $2,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Grayhawk Investment Strategies Inc. Portfolio

Follow Grayhawk Investment Strategies Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grayhawk Investment Strategies Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grayhawk Investment Strategies Inc. with notifications on news.